US Patent 11174240 Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride
Patent 11174240 was granted and assigned to Aptabio Therapeutics on November, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+252 characters)
Article
Patent abstract
The present invention relates to a novel crystalline 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride, a method for preparing the compound, and a pharmaceutical composition containing the compound as an active ingredient.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111742400
Date of Patent
November 16, 2021
0Patent Application Number
166053800
Date Filed
April 20, 2018
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
111742400
Date of Patent
November 16, 2021
0Patent Application Number
166053800
Date Filed
April 20, 2018
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11174240 Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11174240
Date of patent
November 16, 2021
Patent application number
16605380
Date Filed
April 20, 2018
Patent primary examiner
Find more entities like US Patent 11174240 Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
